Carl Zeiss Meditec Introduces New Suite of Ophthalmic Innovations

Surgical Products, Software Enhancements and Diagnostic Platforms Streamline Efficiencies from the Clinic to the Operating Room
AAO 112th Annual Meeting
Booth #3608

Carl Zeiss Meditec, a leader in complete ophthalmic systems including IOLs and disposables, today announced the newest innovations to its technology offering at the American Academy of Ophthalmology (AAO) meeting in Atlanta, GA. These new systems include diagnostic and surgical applications covering the entire spectrum of patient care and supporting all major segments of ophthalmology, including cataract/refractive, retina and glaucoma.

“Our new innovations at this meeting are designed to provide the clinician with better diagnostic and treatment options while streamlining efficiency in the practice,” said Michael Kaschke, President and Chief Executive Officer of Carl Zeiss Meditec. “Our goal is to be the partner that our customers can depend on today and for years to come, by providing technologies that stand the test of time and programs that address their unique needs and practice environments.”

At this year’s AAO meeting, Carl Zeiss Meditec will introduce two new systems.
The new OPMI Lumera® i Surgical Microscope offers the same patented Stereo Coaxial Illumination (SCI) as the OPMI Lumera®, introduced just one year ago, with the addition of new integrated workflow efficiencies designed specifically for the operating room environment. These new features include a touch-screen control panel, integrated camera control and an ergonomic foot pedal.
The new VISULAS Trion™ Combi System is the world’s first multi-color photocoagulator paired with a photodisruptor to offer the complete treatment solution for the retina practice. Using yellow, red and green wavelengths, surgeons can perform a variety of retinal procedures with the added capability to perform iritdotomies with the companion YAG laser.

“I have come to rely on the Carl Zeiss Meditec brand for consistent and reliable technologies that are at the forefront of innovation and patient care,” said Ike Ahmed, MD, Assistant Professor at the University of Toronto, Ontario. “As a user of Cirrus HD-OCT, IOLMaster, Atlas, Visante OCT and GDx, I find that the newest products have evolved to not only deliver improved clinical confidence and optimal outcomes, but also provide practice efficiencies that save time and simplify processes for our staff and patients.”

In addition to these new products, Carl Zeiss Meditec will showcase several recent innovations for its Optical Coherence Tomography (OCT) and IOLMaster™ Biometry systems. Stratus OCT™ and Cirrus™ HD-OCT collectively reached a milestone of 10,000 placements worldwide in September and the IOLMaster™ similarly reached a landmark 10,000 installations this month. The new advancements are designed to improve the scalability and clinical applications of these products.
Cirrus™ HD-OCT Review Software brings the capabilities of Cirrus™ HD-OCT analysis to the exam lane. To streamline office workflow, this new software enables dynamic viewing of images and analyses at a remote location, such as a laptop or personal computer. Additional applications in development for OCT will be previewed in the New Technology area of the exhibition booth.
IOLMaster™ Advanced Technology Software Version 5 offers a new composite axial length algorithm that increases the number of patients that can be measured for intraocular lenses (IOLs), including those suffering from dense, opaque cataracts and those who have undergone hyperopic laser vision correction.

Key refractive solutions at this year’s meeting include the VisuMax® Femtosecond System and MEL 80™ for laser vision correction as well as the Acri.LISAtoric multifocal intraocular lenses for refractive cataract surgery. Meeting delegates are encouraged to attend the “Innovations in Refractive Surgery” and “Innovations in Ocular Surgery” symposia to learn more about the recent clinical outcomes achieved with these refractive and IOL products.
The VisuMax® Femtosecond System and the MEL 80™ excimer laser are achieving excellent outcomes at three Centers of Excellence within the United States, including Baskin-Palmer Eye Institute in Miami, FL, Discover Vision Center in Kansas City, MO and Dishler Laser Institute in Greenwood Village, CO.
Acri.LISAtoric, the world’s only multifocal toric MICS IOL, was launched at ESCRS 2008 and will debut in the U.S. for the first time at this meeting at booth #3600. An international multi-center study is currently underway at approximately 20 centers throughout the UK, Europe and Asia. The Acri.LISAtoric is based on the well-known optical concept of the Acri.LISA which has shown in studies that the vast majority of patients, in some studies more than 90% of the patients, no longer need corrective glasses at all after cataract surgery. The Acri.LISAtoric is not approved for sale in the U.S.

Carl Zeiss Meditec’s connectivity solution, featuring the VISUPAC® Star and DICOM Gateway image and report management solution, will be previewed at the New Technology area of the exhibition booth. The VISUPAC Star offers centralized storage for test reports and clinical images generated by the clinic’s diagnostic instruments. It also provides a new patient scheduler feature which eliminates the need for typing patient information into each diagnostic instrument, thereby saving time and preventing charting errors.

New customizable financing programs, designed to meet the unique needs of each practice, are also available for the first time at this meeting. And, as Carl Zeiss Meditec is committed to supporting the ophthalmic community through ongoing education, several CME and non-CME programs will be offered in Atlanta throughout the duration of the conference. Delegates may register for these events by visiting http://www.zeiss.com/aao.

Brief Profile:

Carl Zeiss Meditec AG (ISIN: DE 0005313704) is one of the world’s leading medical technology companies. This market position is based on over 160 years of experience in optical innovation.

The company has two primary areas of activity: In the field of ophthalmology Carl Zeiss Meditec offers integrated solutions for treating the four main eye diseases: vision defects (refraction), cataracts, glaucoma and retinal disorders. The company’s system solutions are employed in all phases of the disease management, from diagnosis to treatment and follow-up. Carl Zeiss Meditec has always applied its technological expertise to product innovations. These innovations range from basic systems such as slit lamps and fundus cameras to standard setting diagnostic systems such as the Humphrey® Field Analyzer, the Cirrus™ HD-OCT and the IOLMaster®, through to the surgical microscopes and innovative treatment systems in refractive laser surgery. The product portfolio in ophthalmic surgery is rounded off by intraocular lenses and consumables.

In the field of neuro and ENT surgery, Carl Zeiss Meditec is the world’s leading provider of surgical microscopes and microsurgical visualisation solutions for a very broad range of applications, such as tumor and vascular surgery in the head region and/or spinal surgery. The most recent example of our innovative performance in the area of microsurgery is the OPMI Pentero® visualisation system, which allows efficient and ergonomic patient treatment. Carl Zeiss Meditec will systematically expand its product range in this area and become a solution provider in neuro and ENT surgery as well.

Carl Zeiss Meditec’s medical technology portfolio is rounded off by visualisation systems for doctors in private practice and promising future technologies such as intraoperative radiation therapy, which allows the targeted treatment of breast cancer and brain cancer directly during surgery.

An aging global population, rising expectations of doctors and patients, together with innovative treatment methods in medical technology are expected to promote market growth in the long term. Carl Zeiss Meditec holds an optimum position for future developments in the health sector. The company focuses its solution portfolio on the three medical challenges with a significant social and economic impact: loss of mobility, vision and cognitive abilities. The goal is to deliver technologies and application-oriented solutions that allow doctors to improve the quality of life of their patients and to further improve the efficiency of diagnosis and treatment.

Carl Zeiss Meditec AG is based in Jena, Germany, with subsidiaries in Germany (Carl Zeiss Surgical GmbH, Carl Zeiss Meditec Vertriebsgesellschaft mbH, Acri.Tec AG and Carl Zeiss Medical Software GmbH), the USA (Carl Zeiss Meditec, Dublin California), in Japan (Carl Zeiss Meditec Co., Ltd., Tokyo), Spain (Carl Zeiss Meditec Iberia S.A., Madrid) and France (Carl Zeiss Meditec S.A.S, La Rochelle, and Carl Zeiss Meditec France SAS, Le Pecq).

Thirty-five percent of the Carl Zeiss Meditec shares are in free float. The remaining 65 percent are held by Carl Zeiss, one of the world’s leading international groups engaged in the optical and opto-electronics industry.

Contacts

CoActive Public Relations
Carmen Caricchio, 415-621-6626
czm {at} coactivepr(.)com